257 Transcriptomic and Proteomic Modulation in Psoriatic Skin Following Envudeucitinib Treatment: Subgroup Analysis of a Phase 2 Randomized Trial
Journal of Investigative Dermatology · 2025-11 · 145 (11) · e71
DOI: 10.1016/j.jid.2025.09.261 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Investigative Dermatology, 2025-11. Verfasst von Jerry Zhou und 14 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhou, J., Fiedler, J., Duca, E. D., Rosa, J. C. D., Pulsinelli, J., Estrada, Y., Patel, M., Singh, D. G., Lin, X., Metukuru, R., Shah, M., Tilley, M., Tseng, A., Hoffman, J., & Guttman-Yassky, E. (2025). 257 Transcriptomic and Proteomic Modulation in Psoriatic Skin Following Envudeucitinib Treatment: Subgroup Analysis of a Phase 2 Randomized Trial. Journal of Investigative Dermatology, 145(11), e71. https://doi.org/10.1016/j.jid.2025.09.261
Vancouver
Zhou J, Fiedler J, Duca ED, Rosa JCD, Pulsinelli J, Estrada Y, et al. 257 Transcriptomic and Proteomic Modulation in Psoriatic Skin Following Envudeucitinib Treatment: Subgroup Analysis of a Phase 2 Randomized Trial. Journal of Investigative Dermatology. 2025;145(11):e71. doi:10.1016/j.jid.2025.09.261
BibTeX
@article{Zhou2025,
author = {Zhou, Jerry and Fiedler, Jacob and Duca, Ester Del and Rosa, Joel Correa da and Pulsinelli, Juliana and Estrada, Yeriel and Patel, Manishkumar and Singh, Digpal Gour and Lin, Xinyi and Metukuru, Ragasruti and Shah, Manali and Tilley, Mera and Tseng, Alex and Hoffman, Josh and Guttman-Yassky, Emma},
title = {257 Transcriptomic and Proteomic Modulation in Psoriatic Skin Following Envudeucitinib Treatment: Subgroup Analysis of a Phase 2 Randomized Trial},
journal = {Journal of Investigative Dermatology},
year = {2025},
volume = {145},
number = {11},
pages = {e71},
doi = {10.1016/j.jid.2025.09.261}
}
EUVIMED